Copyright © 2021. Inderes Oyj. All rights reserved.
Käyttäjätili

Hei anonyymi!

Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.

Luo tili

Onko sinulla jo Inderes-tili?

Evolution Gaming Group

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
3.2.
2023

Redeye updates its view on Evolution post Q4-results which came in just above our expectations and we have slightly raised our estimates and valuation range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

Tiedotteet
2.2.
2023
Fourth quarter of 2022 (Q4 2021)
  • Operating revenues increased by 36% to EUR 407.5 million (300.2)
  • EBITDA increased by 35% to EUR 279.5 million (206.9), corresponding to a margin of 68.6% (68.9)
  • Profit for the period amounted to EUR 223.5 million (171.6)
  • Earnings per share amounted to EUR 1.05 (0.80)
Full-year 2022 (2021)
  • Operating revenues increased by 36% to EUR 1,456.7 million (1,068.8)
  • EBITDA increased by 37% to EUR 1,008.4 million (734.7), corresponding to a margin of 69.2% (68.7)
  • Profit for the year amoun
Tiedotteet
23.1.
2023

Evolution AB (publ), 556994-5792, holds an extraordinary general meeting on 16 February 2023 at 14.00 (CET) on Strandvägen 7A in Stockholm, Sweden. Entry and registration begin at 13.30 (CET).

Tiedotteet
2.11.
2022

Redeye updates on Evolution post Q3-results which came in stronger than expected driven by better than forecasted revenue growth while profitability was in line with expectations.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

Muut analyysit
1.11.
2022

Redeye updates on Evolution post Q3-results which came in stronger than expected driven by better than forecasted revenue growth while profitability was in line with expectations.

Muut analyysit
27.10.
2022

Redeye comments on Evolution’s Q3-results which came in above our expectations due to stronger sales than expected while profitability was in line with expectations.

Tiedotteet
27.10.
2022
Third quarter of 2022 (Q3 2021)
  • Operating revenues increased by 37.1% to EUR 378.5 million (276.0)
  • EBITDA increased by 35.3% to EUR 261.0 million (192.9), corresponding to a margin of 69.0% (69.9)
  • Profit for the period amounted to EUR 221.3 million (157.4)
  • Earnings per share amounted to EUR 1.04 (0.73)
January-September2022 (9M 2021)
  • Operating revenues increased by 36.5% to EUR 1,049.3 million (768.5)
  • EBITDA increased by 38.1% to EUR 728.9 million (527.7), corresponding to a margin of 69.5% (68.7)
  • Profit for t
Tiedotteet
3.10.
2022

In accordance with the resolution of the Annual General Meeting, the three largest shareholders in the company as per the last business day of August who wish to appoint a representative shall appoint the Nomination Committee. If any of these shareholders chooses to waive their right to elect a representative, their right is transferred to the shareholder who, after these shareholders, has the largest share ownership and wishes to use this right.

Tiedotteet
8.8.
2022

As Evolution AB (publ) published on 22 June 2022, Evolution AB (publ)'s wholly-owned subsidiary, Evolution Malta Holding Limited ("Evolution"), has entered into an agreement to acquire the entire issued share capital of Nolimit City Holding Ltd for a consideration payable in cash (the "Transaction"). All regulatory approvals that the Transaction was conditional upon have been received, and Evolution has today completed the Transaction and acquired Nolimit City.

Tiedotteet
27.7.
2022

Redeye updates on Evolution post Q2-results which came in slightly lower than expected. While we trim our estimates (2022-24E EBITDA down c. 2-3%) due to slower than expected growth in Asia, we are positive to the solid growth in US and the increased share of regulated revenue.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

Evolution Gaming Group